Cite
HARVARD Citation
Muto, Y. et al. (2018). Success of rechallenging dabrafenib and trametinib combination therapy after trametinib-induced rhabdomyolysis. Melanoma research. 28 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Muto, Y. et al. (2018). Success of rechallenging dabrafenib and trametinib combination therapy after trametinib-induced rhabdomyolysis. Melanoma research. 28 (2), p. . [Online].